Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 4
1998 1
1999 3
2000 1
2001 3
2002 2
2003 8
2004 13
2005 5
2006 8
2007 9
2008 7
2009 8
2010 9
2011 15
2012 8
2013 8
2014 7
2015 8
2016 9
2017 6
2018 2
2019 5
2020 3
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Results by year
Filters applied: . Clear all
Page 1
Head and neck cancer.
Argiris A, Karamouzis MV, Raben D, Ferris RL. Argiris A, et al. Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X. Lancet. 2008. PMID: 18486742 Free PMC article. Review.
Pemetrexed in head and neck cancer: a systematic review.
Argiris A, Pennella E, Koustenis A, Hossain AM, Obasaju CK. Argiris A, et al. Oral Oncol. 2013 Jun;49(6):492-501. doi: 10.1016/j.oraloncology.2013.01.007. Epub 2013 Mar 7. Oral Oncol. 2013. PMID: 23466170 Review.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
Soria JC, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Isla D, Guclu SZ, Morabito A, Min YJ, Ardizzoni A, Gadgeel SM, Wang B, Chand VK, Goss GD; LUX-Lung 8 Investigators. Soria JC, et al. Lancet Oncol. 2015 Aug;16(8):897-907. doi: 10.1016/S1470-2045(15)00006-6. Epub 2015 Jul 5. Lancet Oncol. 2015. PMID: 26156651 Clinical Trial.
Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.
Garas G, Markar SR, Malietzis G, Ashrafian H, Hanna GB, Zacharakis E, Jiao LR, Argiris A, Darzi A, Athanasiou T. Garas G, et al. Among authors: argiris a. Ann Surg Oncol. 2018 Jan;25(1):221-230. doi: 10.1245/s10434-017-6210-y. Epub 2017 Nov 6. Ann Surg Oncol. 2018. PMID: 29110271 Free PMC article. Review.
A randomized phase II study of ixabepilone (BMS-247550) given daily x 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: an Eastern Cooperative Oncology Group study.
Burtness BA, Manola J, Axelrod R, Argiris A, Forastiere AA; Eastern Cooperative Oncology Group. Burtness BA, et al. Among authors: argiris a. Ann Oncol. 2008 May;19(5):977-83. doi: 10.1093/annonc/mdm591. Epub 2008 Feb 21. Ann Oncol. 2008. PMID: 18296423 Free article. Clinical Trial.
144 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page